Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fry

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Advances in Enzyme Regulation|January 1, 1989
Biochemical pharmacology and antitumor properties of 4-amino-8-[beta-D-ribofuranosylamino]pyrimido-[5,4-d]pyrimidineR C Jackson, T J Boritzki, P D Cook, et al.
Advances in Enzyme Regulation|January 1, 1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activityR C Jackson, D W Fry, T J Boritzki, et al.
Investigational New Drugs|January 1, 1985
Dezaguanine mesylate: a new antipurine antimetaboliteW R Leopold, D W Fry, T J Boritzki, et al.
Journal of Medicinal Chemistry|June 24, 1994
Tyrosine kinase inhibitors. 3. Structure-activity relationships for inhibition of protein tyrosine kinases by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)G W Rewcastle, B D Palmer, E M Dobrusin, et al.
Progress in Clinical and Biological Research|January 1, 1986
The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technologyS N Rhinehart, W M Dugan, P J Parashos, et al.
American Journal of Obstetrics and Gynecology|December 17, 2008
The clinical content of preconception care: care of psychosocial stressorsLorraine V Klerman, Brian W Jack, Dean V Coonrod, et al.
Journal of Medicinal Chemistry|May 9, 1997
Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of bindingB D Palmer, S Trumpp-Kallmeyer, D W Fry, et al.
Journal of the Pediatric Orthopaedic Society of North America|February 4, 2026
Osteogenesis Imperfecta or Non-accidental Trauma? The Diagnostic Dilemma in Pediatric FracturesOmar Taha, Matthew Weintraub, Mehdi M Elfilali, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|July 1, 1997
Influence of exercise-induced plasma volume changes on the interpretation of biochemical data following high-intensity exerciseS Kargotich, C Goodman, D Keast, et al.
Oncogene|January 16, 2002
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor familyPhilippe C Bishop, Timothy Myers, Robert Robey, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Advances in Enzyme Regulation|January 1, 1989
Biochemical pharmacology and antitumor properties of 4-amino-8-[beta-D-ribofuranosylamino]pyrimido-[5,4-d]pyrimidineR C Jackson, T J Boritzki, P D Cook, et al.
Advances in Enzyme Regulation|January 1, 1985
The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activityR C Jackson, D W Fry, T J Boritzki, et al.
Investigational New Drugs|January 1, 1985
Dezaguanine mesylate: a new antipurine antimetaboliteW R Leopold, D W Fry, T J Boritzki, et al.
Journal of Medicinal Chemistry|June 24, 1994
Tyrosine kinase inhibitors. 3. Structure-activity relationships for inhibition of protein tyrosine kinases by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)G W Rewcastle, B D Palmer, E M Dobrusin, et al.
Progress in Clinical and Biological Research|January 1, 1986
The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technologyS N Rhinehart, W M Dugan, P J Parashos, et al.
American Journal of Obstetrics and Gynecology|December 17, 2008
The clinical content of preconception care: care of psychosocial stressorsLorraine V Klerman, Brian W Jack, Dean V Coonrod, et al.
Journal of Medicinal Chemistry|May 9, 1997
Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of bindingB D Palmer, S Trumpp-Kallmeyer, D W Fry, et al.
Journal of the Pediatric Orthopaedic Society of North America|February 4, 2026
Osteogenesis Imperfecta or Non-accidental Trauma? The Diagnostic Dilemma in Pediatric FracturesOmar Taha, Matthew Weintraub, Mehdi M Elfilali, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|July 1, 1997
Influence of exercise-induced plasma volume changes on the interpretation of biochemical data following high-intensity exerciseS Kargotich, C Goodman, D Keast, et al.
Oncogene|January 16, 2002
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor familyPhilippe C Bishop, Timothy Myers, Robert Robey, et al.
Pageof 21